Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer

Expert Reviews in Molecular Medicine
Anna L StratfordSandra E Dunn

Abstract

Tumour recurrence is one of the biggest challenges in breast cancer management because it affects 25-30% of women with breast cancer and the tumours are often incurable. Women with triple-negative breast cancer (TNBC--lacking expression of the oestrogen receptor, progesterone receptor and the receptor HER2/ERBB2) have the highest rates of early recurrence relative to other breast cancer subtypes. Early recurrence might be due to tumour-initiating cells (TICs), which are resistant to conventional therapies, can remain dormant and can subsequently give rise to secondary tumours. In breast cancer, TICs are identified by the cell-surface markers CD44+/CD24-/EpCAM+ and/or possess ALDH1 enzyme activity. This subpopulation has the ability to self-renew, grow as mammospheres and initiate tumour formation. Fuelling the problem of relapse is the fact that chemotherapy and radiation can induce or select for TICs; this was reported in preclinical models and more recently in women being treated for breast cancer. Thus, new therapeutic agents for TNBC are presently being sought to overcome this problem. Here we review the roles of receptor tyrosine kinases, signalling intermediates and transcription factors in sustaining the TIC subpopulatio...Continue Reading

Associated Clinical Trials

References

Feb 1, 1976·Acta Radiologica: Therapy, Physics, Biology·A WallgrenG Eklund
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R H ChenJ Blenis
Jun 2, 1997·The EMBO Journal·G J SchoutenA Zantema
Apr 7, 1998·Molecular and Cellular Biology·P B JoelD A Lannigan
Feb 19, 2000·Current Biology : CB·A ShimamuraJ Blenis
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Dec 5, 2002·Genes & Development·Véronique Orian-RousseauHelmut Ponta
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Apr 2, 2003·Human Molecular Genetics·Chu-Xia Deng, Rui-Hong Wang
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Jan 20, 2004·Journal of Medical Genetics·W D Foulkes
Mar 3, 2004·The Journal of Biological Chemistry·Mutsuko OuchiToru Ouchi
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Sep 3, 2004·Nature Reviews. Cancer·Steven A Narod, William D Foulkes
Mar 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Alana L WelmJ Michael Bishop
May 12, 2005·Journal of Mammary Gland Biology and Neoplasia·Gabriela Dontu, Max S Wicha
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Saori FurutaWen-Hwa Lee
Sep 20, 2005·Cancer Cell·Susan E MoodyLewis A Chodosh
Oct 11, 2005·Current Biology : CB·Rana AnjumJohn Blenis
Jan 6, 2006·Nature·John StinglConnie J Eaves
Feb 21, 2006·Cancer Research·Max S WichaGabriela Dontu
Jul 20, 2006·Journal of the National Cancer Institute·Marie-Liesse Asselin-LabatGeoffrey J Lindeman
Sep 26, 2006·Nature Medicine·Liqing JinJohn E Dick
Sep 26, 2006·Oncogene·N C Turner, J S Reis-Filho
Oct 17, 2006·The Biochemical Journal·Gopal P SapkotaDario R Alessi
Oct 26, 2006·Breast Cancer Research : BCR·Carol SheridanHarikrishna Nakshatri
Dec 21, 2006·Journal of the National Cancer Institute·Tiffany M PhillipsFrank Pajonk
Jan 11, 2007·The Journal of Pathology·A McCarthyA Ashworth
Jan 19, 2007·The New England Journal of Medicine·Rui LiuMichael F Clarke
Jan 30, 2007·Nature Chemical Biology·Michael S CohenJack Taunton

❮ Previous
Next ❯

Citations

May 3, 2011·Clinical & Experimental Metastasis·Joseph A Caruso, Paul M Stemmer
Feb 12, 2011·Carcinogenesis·Fares Al-EjehKum Kum Khanna
Mar 6, 2012·Seminars in Radiation Oncology·Thomas B BrunnerMichael Baumann
Jan 13, 2011·Pediatric Blood & Cancer·Li-Zhi ZhangBing-Fang Zeng
Oct 14, 2014·Expert Opinion on Therapeutic Targets·Anselmo PapaFederica Tomao
Jun 16, 2016·Scientific Reports·Jiefu JinZaver M Bhujwalla
Jan 26, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·M Veiseh, E A Turley
Nov 21, 2019·International Journal of Cancer. Journal International Du Cancer·Wolfgang S LiebAngelika Hausser
Sep 22, 2018·Molecular Cancer Therapeutics·Khoa NguyenV Lokesh Battula
Oct 6, 2011·Molecular Cancer Research : MCR·Jeanne M V Louderbough, Joyce A Schroeder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.